Can a simple screening tool help cancer centers support families better?
NCT ID NCT04446728
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two strategies for helping pediatric cancer centers use the Psychosocial Assessment Tool (PAT), a questionnaire that identifies family emotional, social, and practical needs after a child's cancer diagnosis. Eighteen cancer programs across the U.S. are randomly assigned to receive either a basic training webinar or enhanced support including a local champion and monthly calls. The goal is to see which approach leads to more families being screened and better staff engagement, without directly treating the cancer itself.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Psychosocial Assessment Tool (PAT) screening and implementation strategies (training webinar, champion, consultation calls)
- What this could lead to
- If successful, this could show the best way for cancer centers to routinely screen families for emotional and social needs, leading to better support for children with cancer and their families.
- What could go wrong
- This is a small, early-stage implementation study (18 sites) focused on process, not patient health outcomes. Results may not apply to all centers, and the screening tool itself may not improve care if follow-up resources are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
18 people
The number who actually took part.
- Started
-
Jan 2021
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Sites were selected in advance based on data collected in a previous study regarding psychosocial staffing in the pediatric cancer program. * Sites that were at or above the median for size of their psychosocial staff were eligible. - -- * Site selection took into consideration number of new pediatric cancer patients annually, geographical representation and sites with significant proportions of Spanish speaking families and/or families of low socioeconomic status. Exclusion Criteria: \- Sites with psychosocial staffing below the median in the prior study were not eligible.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pediatric cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nemours Children's Health
Wilmington, Delaware, 19083, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can freezing ovarian tissue protect fertility in children facing cancer treatment?
- Tumor profiling may unlock targeted drug options for pediatric cancers
- Can a new pill tame childhood cancers that Won't quit?
- A bike ride could reveal hidden heart risks in young cancer survivors
- Can a new combo drug tame childhood leukemia that Won't quit?
- Can a Tumor's genetic blueprint guide better treatment for kids with brain cancer?